Evidence map›Paper›PMID 16009933›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung.

Tiina M Asikainen, Barbara K Schneider, Nahid S Waleh, Ronald I Clyman, Wen-Bin Ho, Lee A Flippin, Volkmar Günzler, Carl W White

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Hypoxia-Inducible Factor-1α in SM22α-Expressing Cells Modulates Alveolarization.American journal of respiratory cell and molecular biology · 2023
    Article
  3. Review
  4. Article
  5. SM22α cell-specific HIF stabilization mitigates hyperoxia-induced neonatal lung injury.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  6. Article
  7. Article
  8. Cellular clocks in hyperoxia effects on [CaAmerican journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Tiina M AsikainenDepartment of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206, USA.
Barbara K Schneider
Nahid S Waleh
Ronald I Clyman
Wen-Bin Ho
Lee A Flippin
Volkmar Günzler
Carl W White
National Jewish Health · USUniversity of Colorado Denver · USFibroGen (United States) · USUniversity of California, San Francisco · US

Funding

WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GAUDUIN, MARIE-CLAIRE ELISABETH · 1999 to 2011
$79.1M
COLLABORATIVE PROGRAM IN BPDU01HL052636 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI COALSON, JACQUELINE JONES · 1999 to 2007
$18.1M
Hypoxia-inducible factors bronchopulmonary dysplasia-BPDU01HL056263 · NHLBI · NATIONAL JEWISH HEALTH · PI WHITE, CARL W · 1999 to 2006
$1.5M
COLLABORATIVE PROGRAM IN BPDR10HL052636 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI COALSON, JACQUELINE JONES · 1994 to 1994
–
COLLABORATIVE PROGRAM IN BPDU10HL052636 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI COALSON, JACQUELINE JONES · 1994 to 1998
–
NCRR NIH HHS P51 RR013986NCRR NIH HHS P51RR13986NHLBI NIH HHS HL52636NHLBI NIH HHS U01 HL052636NHLBI NIH HHS U01 HL056263NHLBI NIH HHS U01 HL56263
6 · The paper itself

Abstract

Preterm neonates with respiratory distress syndrome (RDS) often develop a chronic form of lung disease called bronchopulmonary dysplasia (BPD), characterized by decreased alveolar and vascular development. Ventilator treatment with supraphysiological O2 concentrations (hyperoxia) contribute to the development of BPD. Hyperoxia down-regulates and hypoxia up-regulates many angiogenic factors in the developing lung. We investigated whether angiogenic responses could be augmented through enhancement of hypoxia-inducible factors 1alpha and 2alpha (HIF-1alpha and -2alpha, respectively) via blockade of prolyl hydroxylase domain-containing proteins (HIF-PHDs) in human microvascular endothelial cells from developing and adult lung, in epithelial A549 cells, and in fetal baboon explants in relative or absolute hyperoxia. PHD inhibitor (FG-4095) and positive control dimethyloxaloylglycine (DMOG), selective and nonselective HIF-PHD inhibitors, respectively, enhanced HIF-1alpha and -2alpha, vascular endothelial growth factor (VEGF), and platelet-endothelial cell adhesion molecule 1 expression in vitro in 95% and 21% O2. Furthermore, VEGF receptor fms-like tyrosine kinase 1 (Flt-1) was elevated, whereas kinase insert domain-containing receptor/fetal liver kinase 1 (KDR) was diminished in endothelial, but not epithelial, cells. Intracellular Flt-1 and KDR locations were unchanged by PHD blockade. Like VEGF, FG-4095 and DMOG increased angiogenesis in vitro, both in 95% and 21% O2, an effect that could be blocked through either Flt-1 or KDR. Notably, FG-4095 was effective in stimulating HIFs and VEGF also in fetal baboon lung explants. FG-4095 or DMOG treatment appeared to stimulate the feedback loop promoting HIF degradation in that PHD-2 and/or -3, but not PHD-1, were enhanced. Through actions characterized above, FG-4095 could have desirable effects in enhancing lung growth in BPD.

Indexed as

Amino Acids, DicarboxylicAnalysis of VarianceAnimalsBasic Helix-Loop-Helix ProteinsBlotting, WesternEndothelial CellsEndothelial PAS Domain-Containing Protein 1Enzyme-Linked Immunosorbent AssayGene Expression RegulationHumansHyperoxiaHypoxia-Inducible Factor 1, alpha SubunitLungNeovascularization, PhysiologicOxygenPapioAmino Acids, DicarboxylicBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1HIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitoxalylglycineOxygenProcollagen-Proline DioxygenaseTrans-ActivatorsTranscription FactorsVascular Cell Adhesion Molecule-1Vascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID16009933
PMCPMC1177409
OpenAlexW1981569442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.